PD-L1 has made substantial progress in the treatment of NSCLC, and PD-L1-targeted CAR-T cells have strong cytotoxic effects against NSCLC both in vivo and in vitro [156, 157]. Here, CD274 is linked to non-small cell lung carcinoma.